Treatment of Progressive Multifocal Leukoencephalopathy with IL-2 and Mirtazapine

Affiliations

• ¹ Department of Medicine, Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
• ² Department of Medicine, Division of Hematology, McGill University Health Centre, Montreal, Quebec, Canada.
• ³ Department of Medicine, Division of Hematology and Oncology, Hôpital Charles-Lemoyne, Longueuil, Quebec, Canada.
• ⁴ Department of Medicine, Division of Infectious Diseases, McGill University Health Centre, Montreal, Quebec, Canada. donald.vinh@mcgill.ca.
• ⁵ IiMMUNO-GRAM (Infection and IMMunity Genetic Research to Advance Molecular medicine) Center of Reference, Research Institute - McGill University Health Centre, 1001 Decarie Blvd; Block E (EM3-3211), Montreal, Quebec, H4A 3J1, Canada. donald.vinh@mcgill.ca.
• ⁶ Department of OptiLab (Division of Medical Microbiology, Division of Molecular Genetics-Immunology), McGill University Health Centre - Research Institute, 1001 Decarie Blvd; Block E; Rm EM3-3230 (Mail Drop: EM3-3211), Montreal, Quebec, H4A 3J1, Canada. donald.vinh@mcgill.ca.
• ⁷ Department of Human Genetics, McGill University Health Centre - Research Institute, 1001 Decarie Blvd; Block E; Rm EM3-3230 (Mail Drop: EM3-3211), Montreal, Quebec, H4A 3J1, Canada. donald.vinh@mcgill.ca.